Tempest Therapeutics, Inc. (TPST)
NASDAQ: TPST · Real-Time Price · USD
9.34
+0.53 (6.02%)
At close: Aug 13, 2025, 4:00 PM
9.37
+0.03 (0.32%)
After-hours: Aug 13, 2025, 7:58 PM EDT
Tempest Therapeutics Market Cap
Tempest Therapeutics has a market cap or net worth of $38.18 million as of August 13, 2025. Its market cap has decreased by -7.12% in one year.
Market Cap
38.18M
Enterprise Value
31.17M
1-Year Change
-7.12%
Ranking
Category
Stock Price
$9.34
Market Cap Chart
Since June 28, 2021, Tempest Therapeutics's market cap has decreased from $88.65M to $38.18M, a decrease of -56.93%. That is a compound annual growth rate of -18.46%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 13, 2025 | 38.18M | 4.83% |
| Dec 31, 2024 | 36.42M | -57.00% |
| Dec 29, 2023 | 84.69M | 600.22% |
| Dec 30, 2022 | 12.09M | -66.85% |
| Dec 31, 2021 | 36.49M | -58.84% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 570.26B |
| Johnson & Johnson | 418.62B |
| AbbVie | 350.91B |
| AstraZeneca | 229.47B |
| UnitedHealth Group | 228.94B |
| Novartis AG | 228.69B |
| Abbott Laboratories | 228.63B |
| Novo Nordisk | 222.88B |